Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP2: TAVT-18 for epilepsy prevention in TSC infants
NCT04595513Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Sep 2020
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
A Phase 2 trial of TAVT-18 in epilepsy, sponsored by Cincinnati Children's Hospital Medical Center. Started Sep 2020; status: completed.
02
Drugs
TAVT-18
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04595513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04595513.